Department of Anesthesiology and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota; and.
Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1001-10. doi: 10.1152/ajpheart.00761.2013. Epub 2014 Jan 31.
Peroxisome proliferator-activated receptor (PPAR)-δ is a nuclear hormone receptor that is mainly involved in lipid metabolism. Recent studies have suggested that PPAR-δ agonists exert vascular protective effects. The present study was designed to characterize vascular function in mice with genetic inactivation of PPAR-δ in the endothelium. Mice with vascular endothelial cell-specific deletion of the PPAR-δ gene (ePPARδ(-/-) mice) were generated using loxP/Cre technology. ePPARδ(-/-) mice were normotensive and did not display any sign of metabolic syndrome. Endothelium-dependent relaxations to ACh and endothelium-independent relaxations to the nitric oxide (NO) donor diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate were both significantly impaired in the aorta and carotid arteries of ePPARδ(-/-) mice (P < 0.05). In ePPARδ(-/-) mouse aortas, phosphorylation of endothelial NO synthase at Ser(1177) was significantly decreased (P < 0.05). However, basal levels of cGMP were unexpectedly increased (P < 0.05). Enzymatic activity of GTP-cyclohydrolase I and tetrahydrobiopterin levels were also enhanced in ePPARδ(-/-) mice (P < 0.05). Most notably, endothelium-specific deletion of the PPAR-δ gene significantly decreased protein expressions of catalase and glutathione peroxidase 1 and resulted in increased levels of H2O2 in the aorta (P < 0.05). In contrast, superoxide anion production was unaltered. Moreover, treatment with catalase prevented the endothelial dysfunction and elevation of cGMP detected in aortas of ePPARδ(-/-) mice. The findings suggest that increased levels of cGMP caused by H2O2 impair vasodilator reactivity to endogenous and exogenous NO. We speculate that chronic elevation of H2O2 predisposes PPAR-δ-deficient arteries to oxidative stress and vascular dysfunction.
过氧化物酶体增殖物激活受体 (PPAR)-δ 是一种核激素受体,主要参与脂质代谢。最近的研究表明,PPAR-δ 激动剂具有血管保护作用。本研究旨在描述内皮细胞中 PPAR-δ 基因缺失的小鼠的血管功能。使用 loxP/Cre 技术生成血管内皮细胞特异性缺失 PPAR-δ 基因的小鼠(ePPARδ(-/-) 小鼠)。ePPARδ(-/-) 小鼠血压正常,没有任何代谢综合征的迹象。ePPARδ(-/-) 小鼠的主动脉和颈动脉对乙酰胆碱的内皮依赖性舒张作用和一氧化氮(NO)供体二乙氨乙基(Z)-1-(N,N-二乙氨基)-1,2-二氮烯-1,2-二醇的内皮非依赖性舒张作用均显著受损(P < 0.05)。在 ePPARδ(-/-) 小鼠主动脉中,内皮型一氧化氮合酶在丝氨酸(Ser)1177 位点的磷酸化显著降低(P < 0.05)。然而,cGMP 的基础水平出人意料地增加(P < 0.05)。ePPARδ(-/-) 小鼠中 GTP 环化水解酶 I 的酶活性和四氢生物蝶呤水平也增强(P < 0.05)。值得注意的是,内皮细胞特异性缺失 PPAR-δ 基因显著降低了 catalase 和谷胱甘肽过氧化物酶 1 的蛋白表达,并导致主动脉中 H2O2 水平升高(P < 0.05)。相比之下,超氧阴离子的产生没有改变。此外,用 catalase 处理可防止检测到的 ePPARδ(-/-) 小鼠主动脉内皮功能障碍和 cGMP 水平升高。这些发现表明,H2O2 引起的 cGMP 水平升高会损害内源性和外源性 NO 引起的血管舒张反应。我们推测,H2O2 的慢性升高使 PPAR-δ 缺乏的动脉易发生氧化应激和血管功能障碍。